<unk> s usually fade gradually over time, and many do not require treatment. However,<unk> s that may be disfiguring or that are located at sites that can cause impairment (eyelids, airway) require early treatment intervention, typically with beta blockers. Management options may include: * Oral beta blockers such as propranolol or atenolol have been used since 2008 and are the first-line treatment of<unk> s. Beta blockers have repeatedly been shown to be effective and safe in treating<unk> s that cause complications. Beta blockers work via multiple mechanisms including narrowing the<unk> 's blood vessels, stopping them from proliferating and bringing forward their natural cell death. These correspond with<unk> s fading and shrinking. Approximately 97% of<unk> s respond to propanolol, with patients under 2 months old showing the greatest improvement. * Topical beta blockers such as timolol. They are most helpful for thin superficial<unk> s. These should not be used in conjunction with oral beta blockers given systemic absorption of topical timolol is known to occur * Corticosteroids * Laser surgery
Hemangioma
Lymphangioma
Angioma
Lymphohemangioma
Angiokeratoma
Chorangioma
Tufted angioma
Chorioangioma